作为精确目标的PDE7:桥梁疾病调制和转化医学潜在的PET成像
Taoqian Zhao1, Steven H Liang1
1Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.
ACS medicinal chemistry letters
|May 14, 2025
概括
固酶7 (PDE7) 调节关键细胞信号,并与各种疾病有关. 新的pyrimidinone抑制剂在治疗疾病和诊断成像应用中都显示出前景.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 固酶7 (PDE7) 对于cAMP-PKA信号传递至关重要,影响免疫反应,神经保护和炎症.
- 异常PDE7活性与神经退行性,自身免疫性和代谢性疾病有关,突出显示了其治疗潜力.
研究的目的:
- 审查PDE7抑制剂的最新进展.
- 探索PDE7抑制剂在治疗和诊断成像中的双重潜力.
主要方法:
- 关于PDE7抑制剂的最新科学文献的综述.
- 基于pyrimidinone的化合物的选择性和有效性的分析.
- 评估放射性标记抑制剂用于正子发射断层扫描 (PET) 成像应用.
主要成果:
- 基于pyrimidinone的PDE7抑制剂具有很高的选择性和强大的生物活性.
- 这些抑制剂显示出作为治疗PDE7相关疾病的治疗剂的前景.
- 放射性标记的PDE7抑制剂正在成为通过PET成像来进行非侵入性疾病监测和治疗评估的宝贵工具.
结论:
- PDE7抑制剂代表了一系列疾病的重要治疗策略.
- 选择性PDE7抑制剂的开发,包括放射性标记的版本,为治疗和诊断成像提供了新的途径.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
104
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
104


